Refine your search
-
Authors
-
Item types
-
Topics
- *Absorbable Implants
- *Cardiovascular Agents/ad [Administration & Dosage]
- *Drug-Eluting Stents [x]
- *Everolimus/ad [Administration & Dosage]
- *Percutaneous Coronary Intervention/is [Instrumentation] [x]
- *Sirolimus/ad [Administration & Dosage]
- Aged
- Cardiovascular Agents/ae [Adverse Effects]
- Everolimus/ae [Adverse Effects]
- Female
- Humans
- Male
- Middle Aged
- Percutaneous Coronary Intervention/ae [Adverse Effects]
- Percutaneous Coronary Intervention/mo [Mortality]
- Prospective Studies
- Prosthesis Design
- Risk Factors
- Sirolimus/ae [Adverse Effects]
- Time Factors
- Show more
- Show less
-
Collections
-
Languages